Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation

被引:0
|
作者
Berg, KA
Stout, BD
Maayani, S
Clarke, WP
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Mt Sinai Sch Med, Dept Anesthesiol, New York, NY USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serotonin (5-HT)(2A) and 5-HT2C, receptors share a high degree of sequence homology and have very similar pharmacological profiles. Although it is generally believed that the cellular signal transduction mechanisms activated by these receptors are indistinguishable, recent data suggest significant differences in their signaling cascades. In this study we explored differences in the characteristics and mechanisms of rapid desensitization between the 5-HT2A and 5-HT2C receptor systems. For both receptor systems, pretreatment with 5-HT reduced the ability of a maximal concentration of 5-HT to stimulate phospholipase C-mediated inositol phosphate accumulation by about 65%, although the 5-HT2C receptor system was more sensitive to the desensitizing stimulus. Differences in the concentration dependence of the rate constant for desensitization (k(des)) suggested different mechanisms of desensitization for the 5-HT2A and 5-HT2C receptor systems. At very high receptor occupancy (>99%), the responsiveness of the 5-HT2A, but not the 5-HT2C, receptor system returned to control levels despite the continued presence of the agonist. This resensitization was dependent upon the activity of protein kinase C (PKC). Agonist-induced desensitization of the 5-HT2A, but not the 5-HT2C, receptor system was reduced by the PKC inhibitors staurosporine and bisindolylmaleimide, and by downregulation of PKC. In addition, inhibitors of calmodulin (W-7) or of calmodulin-dependent protein kinase II, reduced 5-HT2A, but not 5-HT2C, desensitization. Desensitization of the 5-HT2C, but not the 5-HT2A, receptor system was dependent on G protein receptor kinase activity. These data further emphasize the major differences in the signaling systems coupled to 5-HT2A/2C receptors.
引用
收藏
页码:593 / 602
页数:10
相关论文
共 50 条
  • [1] 5-hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C):: Where structure meets function
    Roth, BL
    Willins, DL
    Kristiansen, K
    Kroeze, WK
    [J]. PHARMACOLOGY & THERAPEUTICS, 1998, 79 (03) : 231 - 257
  • [2] Ovarian hormone effects on 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor mRNA expression in the ventral hippocampus and frontal cortex of female rats
    Birzniece, V
    Johansson, IM
    Wang, MD
    Bäckström, T
    Olsson, T
    [J]. NEUROSCIENCE LETTERS, 2002, 319 (03) : 157 - 161
  • [3] Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine2A receptor
    Hanley, NRS
    Hensler, JG
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (02): : 468 - 477
  • [4] Serotonin 5-hydroxytryptamine2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves
    Kurrasch-Orbaugh, DM
    Watts, VJ
    Barker, EL
    Nichols, DE
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (01): : 229 - 237
  • [5] Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors
    Cryan, JF
    Lucki, I
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (03): : 1120 - 1126
  • [6] 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics
    Weiner, DM
    Burstein, ES
    Nash, N
    Croston, GE
    Currier, EA
    Vanover, KE
    Harvey, SC
    Donohue, E
    Hansen, HC
    Andersson, CM
    Spalding, TA
    Gibson, DFC
    Krebs-Thomson, K
    Powell, SB
    Geyer, MA
    Hacksell, U
    Brann, MR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (01): : 268 - 276
  • [7] Antinociception with intrathecal α-Methyl-5-hydroxytryptamine, a 5-hydroxytryptamine2A/2C receptor agonist, in two rat models of sustained pain
    Sasaki, M
    Obata, H
    Saito, S
    Goto, F
    [J]. ANESTHESIA AND ANALGESIA, 2003, 96 (04): : 1072 - 1078
  • [8] Differences in agonist-independent and -dependent 5-Hydroxytryptamine(2C) receptor-mediated cell division
    Westphal, RS
    SandersBush, E
    [J]. MOLECULAR PHARMACOLOGY, 1996, 49 (03) : 474 - 480
  • [9] Regulation of septo-hippocampal activity by 5-hydroxytryptamine2C receptors
    Hajós, M
    Hoffmann, WE
    Weaver, RJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02): : 605 - 615
  • [10] Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine2C receptor
    Rauser, L
    Savage, JE
    Meltzer, HY
    Roth, BL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (01): : 83 - 89